pt. ckd otto pharmaceuticals (facto
Trade trend analysis
Number of Transactions Quantity Weight
Number of Transactions Quantity Weight
The above chart presents the market trend analysis for pt. ckd otto pharmaceuticals (facto from 2025 to 2026. By examining various dimensions such as transaction quantity, transaction weight, average price, and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability. As of 2026, the company has completed 1 transactions, with a transaction quantity of 7000 and a transaction weight of 0.
- Year Transactions Quantity Weight
- 2025 0 0 0
- 2026 1 7000 0
Bill of lading data
< 1/1 >- Trade date 2026/01/23 B/L No. 8050443
- Suppliers fresenius kabi oncology plc Buyers pt. ckd otto pharmaceuticals (facto
- POLs delhi PODs soekarno-hatta apt/jakarta
- Supply area India Purchas area Indonesia
- Weight —— Amount 10271785
- Hs code 29397900 Product tags bat,paclitaxel,retes,sp test,emis,t 10
- Product description PACLITAXEL SEMISYNTHETIC USP TEST 2 BATCH NO 8925NSH016 MFG DT 11 2025 RETEST DT 10 2028 Expand
Partners
Total 1- Rank Company Transactions Per Detail
- 1 fresenius kabi oncology plc indiabuyer,they trade on 2026-01-23 1 100.00% >
Products
Total 6- Products Transactions Per Detail
-
bat
1 100% > -
emis
1 100% > -
paclitaxel
1 100% > -
retes
1 100% > -
sp test
1 100% >
+View All
Hscode rank
Total 1- HSCode Name Transactions Per Detail
- HS 29397900 1 100% >
Port statistics
Total 1- Port Name Transactions Per Detail
- soekarno-hatta apt/jakarta 1 100.00% >